Category Press Releases

Neuraptive Receives FDA Breakthrough Designation for NTX-001 and Updates on Peripheral Nerve Injury Treatment

Neuraptive Therapeutics, Inc. has announced that its therapy NTX-001 has received Breakthrough Therapy Designation from the FDA, which could accelerate its development for patients with peripheral nerve injuries that need…

Read MoreNeuraptive Receives FDA Breakthrough Designation for NTX-001 and Updates on Peripheral Nerve Injury Treatment